Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts
Stephen A. Goutman, Kai Guo, Masha G. Savelieff, et al.
Brain (2022) Vol. 145, Iss. 12, pp. 4425-4439
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Amyotrophic lateral sclerosis
Eva L. Feldman, Stephen A. Goutman, Susanne Petri, et al.
The Lancet (2022) Vol. 400, Iss. 10360, pp. 1363-1380
Open Access | Times Cited: 533
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 237
Amyotrophic lateral sclerosis: translating genetic discoveries into therapies
Fulya Akçimen, Elia R. Lopez, John E. Landers, et al.
Nature Reviews Genetics (2023) Vol. 24, Iss. 9, pp. 642-658
Open Access | Times Cited: 112
Fungal Metabolomics: A Comprehensive Approach to Understanding Pathogenesis in Humans and Identifying Potential Therapeutics
Vinícius Alves, Daniel Zamith‐Miranda, Susana Frasés, et al.
Journal of Fungi (2025) Vol. 11, Iss. 2, pp. 93-93
Open Access | Times Cited: 2
The amyotrophic lateral sclerosis exposome: recent advances and future directions
Stephen A. Goutman, Masha G. Savelieff, Dae-Gyu Jang, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 10, pp. 617-634
Open Access | Times Cited: 40
Longitudinal Metabolomics in Amyotrophic Lateral Sclerosis Implicates Impaired Lipid Metabolism
Kai Guo, Masha G. Savelieff, Dae‐Gyu Jang, et al.
Annals of Neurology (2025)
Open Access | Times Cited: 1
Gut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives
Ahmed Noor Eddin, Mohammed Alfuwais, Reena Noor Eddin, et al.
Nutrients (2024) Vol. 16, Iss. 5, pp. 590-590
Open Access | Times Cited: 7
Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
Juan M. Godoy-Corchuelo, Luis C. Fernández-Beltrán, Zeinab Ali, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1105-1105
Open Access | Times Cited: 23
The pathophysiological role of dihydroceramide desaturase in the nervous system
Fei‐Yang Tzou, Thorsten Hornemann, Jui‐Yu Yeh, et al.
Progress in Lipid Research (2023) Vol. 91, pp. 101236-101236
Closed Access | Times Cited: 15
Gut microbiome correlates with plasma lipids in amyotrophic lateral sclerosis
Kai Guo, Claudia Figueroa‐Romero, Mohamed Noureldein, et al.
Brain (2023)
Open Access | Times Cited: 14
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules
Elena Niccolai, Matteo Pedone, Ilaria Martinelli, et al.
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 4310-4325
Open Access | Times Cited: 5
Advances in Exosome-Based Therapies for the Repair of Peripheral Nerve Injuries
S. Rahimian, Hossein Najafi, Christine A. Webber, et al.
Neurochemical Research (2024) Vol. 49, Iss. 8, pp. 1905-1925
Closed Access | Times Cited: 5
The Role of Sphingomyelin and Ceramide in Motor Neuron Diseases
Gavin McCluskey, Colette Donaghy, Karen Morrison, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1418-1418
Open Access | Times Cited: 21
Extracellular Vesicles in Amyotrophic Lateral Sclerosis
Gavin McCluskey, Karen Morrison, Colette Donaghy, et al.
Life (2022) Vol. 13, Iss. 1, pp. 121-121
Open Access | Times Cited: 19
Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies
John Dou, Kelly M. Bakulski, Kai Guo, et al.
Neurology Genetics (2023) Vol. 9, Iss. 4
Open Access | Times Cited: 12
Associations of neighborhood sociodemographic environment with mortality and circulating metabolites among low-income black and white adults living in the southeastern United States
Kui Deng, Meng Xu, Melis Sahinoz, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Machine learning identified novel players in lipid metabolism, endosomal trafficking, and iron metabolism of the ALS spinal cord
Jack Cheng, Bor‐Tsang Wu, Hsin‐Ping Liu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Gene therapy breakthroughs in ALS: a beacon of hope for 20% of ALS patients
Qing Xie, Kezheng Li, Yinuo Chen, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access
Metabolic dysregulation in amyotrophic lateral sclerosis: insights from 1H NMR-based metabolomics in a tertiary care center in India
Priyanka Gautam, Rahul Yadav, Ranjeet Kumar Vishwakarma, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 5
Closed Access
Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles
Stephen A. Goutman, Jonathan Boss, Gayatri Iyer, et al.
Muscle & Nerve (2022) Vol. 67, Iss. 3, pp. 208-216
Open Access | Times Cited: 17
Abnormal energy metabolism in ALS: a key player?
Thibaut Burg, Ludo Van Den Bosch
Current Opinion in Neurology (2023) Vol. 36, Iss. 4, pp. 338-345
Open Access | Times Cited: 7
Metal mixtures associate with higher amyotrophic lateral sclerosis risk and mortality independent of genetic risk and correlate to self-reported exposures: a case-control study
Dae Gyu Jang, John Dou, Emily J. Koubek, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Disturbances in Muscle Energy Metabolism in Patients with Amyotrophic Lateral Sclerosis
Petra Parvanovova, Petra Hnilicová, Martin Kolísek, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 356-356
Open Access | Times Cited: 2
Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis
Katherine Phan, Ying He, Surabhi Bhatia, et al.
Brain Communications (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 11
The atypical sphingolipid SPB 18:1(14Z);O2 is a biomarker for DEGS1 related hypomyelinating leukodystrophy
Andreas J. Hülsmeier, Sandra P. Toelle, Peter Bellstedt, et al.
Journal of Lipid Research (2023) Vol. 64, Iss. 12, pp. 100464-100464
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top